EHMT1 and Alzheimer disease: Pharmacological inhibition of the histone methyl transferases SUV39H1 and EHMT1/EHMT2 decreases the levels of H3K9me3 in the hippocampus and improves cognitive function in aged mice and a mouse model of AD, respectively [82, 83].